Navigation Links
ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results
Date:3/3/2009

07.

- Cash flow statements

In 2008, ExonHit's net use of cash due to operating activities was EUR 9.6 million compared to EUR 4.9 million in 2007. This difference is mainly due to the increased operating losses and to the increased Research Tax Credit line.

The equipment necessary to strengthen our service laboratory and prepare it for GLP mainly explains the capital expenditure level of EUR 1.2 million in 2008, compared to EUR 1.1 million in 2007.

Due to unfavorable market conditions, financial operations generated EUR 0.2 million in 2008, to be compared with the generation of EUR 13.3 million in 2007.

Product Update

- Diagnostics

EHT Dx21, our internally developed blood diagnostic test for Alzheimer's disease (AD), is undergoing clinical validation. The clinical study EHT AD/002 initiated early in 2008 to recruit blood samples for patients suffering from AD, other dementias and controls achieved its first goal with the recruitment of 311 samples in Q3 2008. The second part of the study was initiated in January 2009 with the recruitment of 250 additional samples making the total number of samples included in the validation the largest for an array based AD blood diagnostic test.

Assuming successful clinical validation, ExonHit Therapeutics plans to launch EHT Dx21 as a Research Use Only product in the clinical trial market in Q4 2009, and in the clinical diagnostic market in a second step through a partnering model.

In February 2009, bioMerieux and ExonHit Therapeutics agreed on new research and development plans as part of their existing collaboration to develop blood-based cancer detection biomarkers. Both companies are jointly pursuing their programs on colorectal and prostate cancers (respectively EHT Dx12 and EHT Dx13) using ExonHit's next generation of human genome-wide SpliceArray(tm) biochips for biomarker disco
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI)
2. ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
3. Loic Maurel Joins Exonhit Therapeutics to Become CEO
4. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
5. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
6. ExonHit Appoints a New Management Board
7. ExonHit Therapeutics - 2007 Financial Results
8. ExonHit Builds A New Organisation
9. ExonHit and bioMerieux Amend Their Strategic Partnership
10. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
11. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... The synthetic rubber industry is ... derivatives as ethylbenzene, a precursor to styrene, used to make styrene-butadiene resins, styrene ... the production of tyres and other components. Thus, growth in the automotive industry ...
(Date:8/3/2015)... -- Aethlon Medical, Inc. (Nasdaq: AEMD ), the pioneer ... today announced that it will host its First Quarter ... August 13, 2015 at 4:30 p.m. Eastern Time. ... of fiscal 2016 first quarter results.  A recorded version ... after the call at the Investor Relations portion of ...
(Date:8/3/2015)... August 3, 2015 According to ... 3D Cell Culture: Asia to ... Research, the global 3D cell culture market was valued at US$ ... at a CAGR of 29.1% to account for US$ ... with TOC:  http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp 3D cell culture ...
(Date:7/31/2015)... , July 31, 2015 In today,s ... that help them drive positive health outcomes, improve ... source of patient care in their communities. At ... tradeshow and conference, AmerisourceBergen announced a new set ... Services Administration Organization and help independent pharmacies endure ...
Breaking Biology Technology:World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 3Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3
... 31, 2011 Fox Chase Cancer Center , one of ... posting of clinical outcomes data to its website as ... cancer care.  This initiative follows on a survey Fox Chase commissioned ... rates as the factor that would be the most ...
... energy-efficient electronic chips could be made using molybdenite. In ... Nature Nanotechnology , EPFL,s Laboratory of Nanoscale Electronics ... material has distinct advantages over traditional silicon or graphene ... at EPFL could play an important role in electronics, ...
... curious about what to expect as a plasma donor ... learn about the process thanks to a new DVD ... Plasma Donor," details the safety and eligibility steps required ... the 400-plus U.S. Food and Drug Administration-licensed and International ...
Cached Biology Technology:Fox Chase Cancer Center Publishes Clinical Outcomes for Patient Use 2Fox Chase Cancer Center Publishes Clinical Outcomes for Patient Use 3New transistors: An alternative to silicon and better than graphene 2New Video on Plasma Donation Available 2
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... Arizona ecologist plans to involve Tucson neighborhoods in a ... ecology designs ways for the natural world to exist ... biodiversity. "The threat to biodiversity is much, much, ... director of UA,s Tumamoc: People & Habitats and of ...
... Digital archives of biomedical images could someday put critical ... can improve the way medicine is practiced. The current ... virtually overwhelmed by the explosion of medical imaging. ... won grants from the National Science Foundation and the ...
... been agonizingly hot in much of the continental U.S., and ... have been looking at ways the Earth might benefit from ... had intrigued them, a premise that melting ice at the ... dioxide, one of the major compounds implicating in warming. ...
Cached Biology News:Reconciliation ecology: The fun way to adapt to climate change 2Reconciliation ecology: The fun way to adapt to climate change 3What the doctor prescribes: Customized medical-image databases 2What the doctor prescribes: Customized medical-image databases 3What the doctor prescribes: Customized medical-image databases 4Ice-free ocean may not absorb CO2, a component in global warming 2Ice-free ocean may not absorb CO2, a component in global warming 3
... PrecisION Ion Channel Cell Lines ,High ... ,Ion channels are well known for having ... function and consequently have a key function ... that modulate ion channels have been investigated ...
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
... antibody raised against a partial ... Immunogen: TOPORS (NP_005793, 98 ... recombinant protein with GST tag. ... NM_005802 ...
Mouse monoclonal antibody raised against a partial recombinant IL31RA. NCBI Entrez Gene ID = IL31RA...
Biology Products: